American Journal of Transplantation Journal
Overview
Publication venue for
- Non-Directed Living Liver Donors for Pediatric Recipients: New Paths to Identifying Potential Donors. 24:S51-S51. 2023
- Single-Center 90Yttrium Outcomes in Early-Intermediate Stage Hepatocellular Carcinoma. 24:S56-S56. 2023
- Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: A multicenter case series and literature review. 23:1972-1979. 2023
- Disseminated Mycobacterium Avium Complex Infection with Bone Marrow Involvement in a Renal Transplant Recipient. 23:S752-S752. 2023
- Ex Situ End Ischemic Hypothermic Oxygenated Perfusion (HOPE) versus Static Cold Storage Prior to Liver Transplantation Positive Interim Results of the Bridge to Hope Pivotal Multicenter Randomized Controlled Clinical Trial on the Safety and Effectiveness of the VitaSmart Liver Machine Perfusion System (clinicaltrils.gov: Nct05045794). 23:S420-S420. 2023
- Incidence, Risk Factors, and Negative Impact of Post-Liver Transplant Delirium: 5-Yyear Experience from a Tertiary Transplant Center. 23:S495-S496. 2023
- Infections After Kidney Transplantation from Donors with Hiv to Recipients with Hiv: Results from the Multicenter Hope in Action Study. 23:S514-S514. 2023
- Neutropenia/Leukopenia and Viral Resistance with Letermovir (LET) vs Valganciclovir (VGCV) as Cytomegalovirus (CMV) Prophylaxis in Adult Kidney Transplant Recipients (KTRs): Results of a Pivotal Randomized Phase 3 Trial. 23:S578-S579. 2023
- Racially Disparate Disease Progression Rates in Early-Stage Hepatocellular Carcinoma Patients. 23:S730-S730. 2023
- Renal Outcomes of High-Risk Kidney Transplant Recipients After Conversion to Belatacept-Based Immunosuppression. 23:S847-S848. 2023
- Safety and Efficacy of Kidney Transplantation from Donors with HIV to Recipients with HIV: Results of the Multicenter Hope in Action Study. 23:S414-S414. 2023
- Single-Center Outcomes of First-Cycle Yttrium-90 for Bridge to Liver Transplantation in Hepatocellular Carcinoma Patients. 23:S729-S730. 2023
- The First 58 Global Kidney Exchange Transplants: Overcoming Multiple Barriers to Transplantation. 23:S344-S344. 2023
- Wait Time Advantage for Transplant Candidates with HIV Who Accept Kidneys from Donors with HIV. 23:S571-S572. 2023
- Critical Variables Driving Patient Outcomes in Early- Stage Hepatocellular Carcinoma with Elevated Risk Factors. 23:S67-S67. 2022
- Ex Situ End Ischemic Hypothermic Oxygenated Perfusion (HOPE) Versus Static Cold Storage Prior to Liver Transplantation - Early Results of the Bridge to HOPE Pivotal Multicenter Randomized Controlled Clinical Trial on the Safety and Effectiveness of the VitaSmart Liver Machine Perfusion System ( clinicaltrils.gov: Nct05045794). 23:S60-S61. 2022
- Single-Center Outcomes of First-Cycle Yttrium-90 for Bridge to Liver Transplantation in Hepatocellular Carcinoma Patients. 23:S36-S36. 2022
- Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis 2022
- Inferior Vena Caval Complications Following Orthotopic Liver Transplant. 22:28-28. 2021
- White paper on antimicrobial stewardship in solid organ transplant recipients 2021
- Albumin Level Prior to Liver-Directed Therapy is a Risk Factor of Waitlist Tumor Progression Independent of HCC Burden. 21:770-771. 2021
- Assessing the Impact of the New Liver Allocation Policy on Transplant Center and Organ Procurement Organization Logistics. 21:788-788. 2021
- Influence of Induction Therapy and Antiretroviral Regimen on Outcomes in HIV Positive Renal Transplant Recipients. 21:369-369. 2021
- Observational Study of the Clinical Characteristics and Shortterm Outcomes of Kidney Transplant Recipients Diagnosed with Coronavirus-19 Infection (sars-cov2) Requiring Hospitalization in New Orleans. 21:608-608. 2021
- Quantifying the Interaction Between Posaconazole and Tacrolimus in Liver Transplant Recipients: A Practical Approach. 21:760-760. 2021
- Assessment Of Hepatic Macrosteatosis Using A Convolutional Deep Neural Network. 20:38-38. 2020
- Biomarkers AFP in Combination with AFP-l3 and DCP Predicts Tumor Progression in Treatment Native HCC Patients. 20:492-493. 2020
- Cirrhosis-Driven Immune Dysfunction is Associated with Poor Response to DEB-TACE and Waitlist Dropout in Hepatocellular Carcinoma Patients While Awaiting Liver Transplantation. 20:492-492. 2020
- Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results. 20:617-619. 2020
- Donor and Recipient Flow Crossmatch Positivity is Associated with Increased Risk of Acute Rejection in Simultaneous Liver-Kidney Transplantations. 20:60-60. 2020
- Effects of Donor Macrosteatosis and Post-Transplant Complement Activation on Early Allograft Dysfunction. 20:60-60. 2020
- Expansion of Immunosuppressive Cell Populations Associates with Tumor-Derived Exosome Shedding in Early-Stage HCC Patients undergoing Locoregional Therapy. 20:60-60. 2020
- High PRA Increases Rejection but Does Not Worsen Renal Function in the First Year Post Kidney Transplant with Alemtuzumab Induction. 20:912-912. 2020
- Increased utilization of liver donors with infectious labels after implementation of a focused education program. 20:38-39. 2020
- Safety Outcomes in Lower-Weight vs Higher-Weight Recipients of Fixed Dose Alemtuzumab for Kidney Transplant Induction. 20:904-905. 2020
- Utilization of Hepatitis C Positive Organs in Kidney Transplantation. 20:881-882. 2020
- Comparable Outcomes of Deceased Donor Liver Transplant Outcomes in Recipients with Previous Abdominal Surgery (PAS) after Pre Listing Surgical Categorization. A Propensity-Score Matched Pair Analysis.. 19:713-714. 2019
- Comparable Outcomes of Deceased Donor Liver Transplants (DDLT) Outcomes in Recipients with Previous Abdominal Surgery (PAS) after Pre-Listing Surgical Categorization. A Propensity-Score Matched Pair Analysis. 19:36-36. 2019
- Evaluation of Liver Function and Biomarkers Predicts Tumor Progression in Treatment-Naive Hepatocellular Carinoma Patients.. 19:767-767. 2019
- Impact of Previous Abdominal Surgeries in Deceased Liver Transplantation. 19:37-37. 2019
- Modified BALAD Score Predicts Incomplete Locoregional Therapy Treatment in Hepatocellular Carcinoma Patients. 19:72-73. 2019
- Patterns and Predictors of Alcohol Use after Early Liver Transplant for Alcoholic Hepatitis.. 19:561-562. 2019
- Perceptions and Attitude of Transplant Clinicians towards Antimicrobial Resistance and Stewardship in Transplant Recipients: A Survey of the American Society Transplantation.. 19:737-737. 2019
- Pre-Treatment Lymphocyte Status in HCC Patients Associates with DEB-TACE Response and Correlates with Increased Regulatory Immune Cells.. 19:762-762. 2019
- Rabbit Anti-Thytnocyte Globulin (rATG) Induction in Heart Transplant Recipients at High Risk for Rejection.. 19:784-785. 2019
- Reduction in Waitlist Time Using HCV Positive Liver Grafts in HCV Negative Recipients.. 19:461-462. 2019
- Safety Outcomes in Elderly Patients Who Receive Alemtuzumab Induction for Kidney Transplant.. 19:820-820. 2019
- Synthetic Liver Function and Absolute Lymphocyte Count in HCC Patients is Associated with Poor Tumor Response to Locoregional Therapy and Increases in Immunosuppressive Cell Populations. 19:73-73. 2019
- The Outcomes after an Infection in Older Liver Transplant Recipients is Comparable to Younger Adults.. 19:418-418. 2019
- Use of HCV Positive Livers in HCV Negative Recipients: The Ochsner Experience. 19:70-70. 2019
- Using 3D Printed Smartphone-Microscope Adapter Tool to Improve Donor Liver Biopsy Evaluation. 19:62-63. 2019
- Adipokines Alter Immune Surveillance & Promote an Aggressive HCC Phenotype. 18:74-74. 2018
- End Stage Renal Disease after Face Transplant.. 18:358-358. 2018
- Endovascular Management of Hepatic Artery Stenosis: Risk Factors and Outcomes. 18:67-68. 2018
- Impact of On-Site Overestimation of Macrosteatosis on Donor Liver Biopsy.. 18:573-573. 2018
- Impact of Total Graft Steatotic Mass in Liver Transplant Outcomes.. 18:573-574. 2018
- Long-Term Effects of Ketoconazole in Rapid Tacrolimus Metabolizers Post-Renal Transplantation.. 18:797-797. 2018
- Lymphopenia in Waitlist Treatment Naive HCC Patients is Associated with Myeloid-Derived Suppressor Cell Expansion and Poor Tumor Response to Doxorubicin-Eluting Bead Transarterial Chemoembolization. 18:85-85. 2018
- Outcomes in Liver and Combined Liver-Kidney Retransplantation.. 18:342-342. 2018
- Outcomes of Livers Allocated to High UNOS Match Sequence Number Recipients at a High Volume Transplant Center.. 18:568-568. 2018
- Portal Vein Thrombosis (PVT) in Liver Transplantation - Recent Experience.. 18:556-557. 2018
- Pre Liver Transplant (LT) Prediction of Surgical Complexity by Recipient Risk Grading and Optimizing Outcomes: The Ochsner Experience.. 18:848-849. 2018
- T Cell Lineage Imbalance and Regulatory Immune Populations in HCC Patients Undergoing Downstaging While Waitlisted for Liver Transplantation.. 18:722-722. 2018
- Effect of Embolization History and Tumor Treatment Response on Plasma TGF beta in HCC Patients Listed for Liver Transplantation. 17:433-433. 2017
- Pre-TACE Immune Status Correlates with Treatment Response and Tumor Biology in HCC as a Bridge to Transplant. 17:436-436. 2017
- Predicting Recurrence Prior to Transplant: The Response of HCC to Chemoembolization. 17:436-437. 2017
- Results of High Risk Donation-after-Circulatory Death (DCD) Donor Liver Transplants. 17:19-19. 2017
- Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy. 17:2155-2164. 2017
- SiLK: Single Incision Approach for Combined Liver Kidney Transplantation. 17:75-75. 2017
- US Outcomes in Early Liver Transplantation for Alcoholic Hepatitis: Results from the American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH). 17:407-407. 2017
- Donor-Recipient Matching in Deceased Donor Liver Transplantation: Analysis of Outcomes Using UNOS Match Sequence Data. 16:77-77. 2016
- Elevated Lung Shunt Fraction as an Independent Predictor of Local Disease Progression and Metastasis in Hepatocellular Carcinoma.. 16:461-462. 2016
- Outcomes of DCD Liver Transplantation Utilizing Donors With High Donor Risk Index. 16:83-83. 2016
- Results from 100 Consecutive Donation-After-Circulatory Death (DCD) Liver Transplants Using a Thrombolytic Protocol.. 16:584-584. 2016
- Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.. 16:793-794. 2016
- Short Duration Perioperative Administration of Ledipasvir/Sofosbuvir Is Safe and Effective in Preventing HCV Recurrence After Liver Transplant.. 16:333-334. 2016
- Susceptibility Patterns of Pre-Transplant Pseudomonas and Post-Lung Transplant Outcomes in Patients with Cystic Fibrosis.. 16:593-593. 2016
- Transcatheter Aortic Valve Replacement (TAVR) for Severe Aortic Stenosis as a Bridge to Liver Transplantation.. 16:676-676. 2016
- Utilizing Imported Liver Grafts for HCC Recipients. 16:82-82. 2016
- Vaccination Compliance in Listed Kidney Transplant Candidates: A Retrospective Chart Review.. 16:731-731. 2016
- Calciphylaxis in Simultaneous Liver-Kidney Transplantation. 15:1105-1109. 2015
- Expanding the Donor Pool: Comparison of Outcomes in DCD vs. Living Donor Liver Transplantation. 15:93-93. 2015
- Is BMI of 28 an Appropriate Cutoff for Simultaneous Pancreas Kidney Transplant in Type II Diabetes?. 15. 2015
- Long Term Outcomes With Alemtuzumab Induction Therapy for Deceased and Living Renal Transplant Recipients. A Single Center Experience. 15. 2015
- Outcomes Following Endovascular Treatment of Hepatic Artery Stenosis Following Liver Transplantation. 15. 2015
- Outpatient Management of Intra-Corporeal Left Ventricular Assist Device System in Children: A Multi-Center Experience. 15:453-460. 2015
- Post-Liver Transplant Delirium Is Associated With Increased Mortality and Prolonged Length of Stay. 15. 2015
- Three Year Outcomes of Renal Allograft Transplants in African American Recipients Receiving Alemtuzumab for Induction Immunosuppression. 15. 2015
- DCD Procurements: Low Incidence of Ischemic Cholangiopathy and Improving Outcomes in Liver Transplantation (LT) from Donation after Circulatory Death (DCD). 14:56-57. 2014
- Improving Outcomes in Liver Transplantation from Donation after Circulatory Death. 14:95-95. 2014
- Role of Special Coagulation Studies for Pre-Operative Screening in Simultaneous Kidney-Pancreas Transplantation. 14:863-863. 2014
- Thrombolytic Protocol Minimizes Ischemic-type Biliary Complications in Liver Transplantation from Donation-After-Cardiac Death Donors. 14:65-65. 2014
- Type 2 Diabetes Mellitus Recipients Achieved Excellent Outcomes in Simultaneous Kidney-Pancreas Transplantation Despite High Post-Operative Weight Gain.. 14:857-858. 2014
- Benefits of a Robotic Donor Nephrectomy Program: A Series of 100 Consecutive Donors.. 13:392-392. 2013
- Liver Transplantation (OLT) Utilizing Donation after Cardiac Death (DCD) Allografts: A Single Center Experience. 13:87-87. 2013
- Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial. 12:3021-3030. 2012
- Excellent Outcomes after Liver Retransplantation for Recurrent HCV: A Single Centre Experience. 12:432-432. 2012
- Late Liver Retransplantation: A Single Center Experience. 12:86-86. 2012
- Peer Review, Performance Improvement and the UNOS Membership and Professional Standards Committee: One Center's Experience. 12:87-87. 2012
- Anti-HBc Positive Donor Livers in Naive Hepatitis B Recipients: 10 Years Experience in a Single Center. 11:202-202. 2011
- Lessons Learned from the Introduction of a Robotic Assisted Donor Nephrectomy Program. 11:73-73. 2011
- Incidence of delayed kidney allograft function in combined heart and kidney transplantation compared with kidney transplant alone, based on OPTN (Organ procurement and transplantation network) data as of December 2006.. 8:347-347. 2008
Identity
International Standard Serial Number (ISSN)
- 1600-6135